Ivan Castellvi (Ivan Castellví, Iván Castellví)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Arthritis research & therapy

Rheumatology international

PloS one

Arthritis & rheumatology (Hoboken, N.J.)

Hospital de la Santa Creu i Sant Pau

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital de la Santa Creu i Sant Pau

Spain

MD; PhD :: RHEUMATOLOGY

Publications

Francisco Javier Narváez, Elena Cañadillas, Ivan Castellvi, Juan José Alegre Sancho, Vanesa Vicens-Zygmunt, Guadalupe Bermudo, Paola Vidal-Montal, Maria Molina-Molina, Joan Miquel Nolla
Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome. Arthritis research & therapy 26 (1) (2024)
Francisco Javier Narváez, Elena Cañadillas, Ivan Castellvi, Juan José Alegre Sancho, Vanesa Vincens-Zygmunt, Guadalupe Bermudo, Paola Vidal-Montal, Maria Molina-Molina, Joan Miquel Nolla
Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome. Arthritis research & therapy 26 (1) (2024)
Francisco Javier Narváez, Elena Canadillas, Ivan Castellvi, Juan José Alegre Sancho, Vanesa Vicens-Zygmunt, Guadalupe Bermudo, Paola Vidal-Montal, Maria Molina-Molina, Joan Miquel Nolla
Correction: Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome. Arthritis research & therapy 26 (1) (2024)
Francisco Javier Narváez, Elena Canadillas, Ivan Castellvi, Juan José Alegre Sancho, Vanesa Vicens-Zygmunt, Guadalupe Bermudo, Paola Vidal-Montal, Maria Molina-Molina, Joan Miquel Nolla
Correction: Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome. Arthritis research & therapy 26 (1) (2024)
Francisco Javier Narváez, Elena Cañadillas, Ivan Castellvi, Juan José Alegre Sancho, Vanesa Vincens-Zygmunt, Guadalupe Bermudo, Paola Vidal-Montal, Maria Molina-Molina, Joan Miquel Nolla
Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome. Arthritis research & therapy 26 (1) (2024)
Ruben Osuna-Gómez, Ivan Castellvi, Maria Mulet, María Angels Ortiz, Douglas E Brough, Helen Sabzevari, Roshanak T Semnani, Silvia Vidal
Impaired Regulation by IL-35 in Systemic Sclerosis. International journal of molecular sciences 24 (13) (2023)
Simon Kuster, Suzana Jordan, Muriel Elhai, Ulrike Held, Klaus Steigmiller, Cosimo Bruni, Fabio Cacciapaglia, Serena Vettori, Elise Siegert, Simona Rednic, Veronica Codullo, Paolo Airo, Yolanda Braun-Moscovici, Nicolas Hunzelmann, Maria Joao Salvador, Valeria Riccieri, Ana-Maria Gheorghiu, Juan José Alegre Sancho, Katarzyna Romanowska-Prochnicka, Ivan Castellvi, Ina Kötter, Marie-Elise Truchetet, F J López-Longo, Pavel I Novikov, Alessandro Giollo, Yuichiro Shirai, Laura Belloli, Elisabetta Zanatta, Eric Hachulla, Vanessa Smith, Chris Denton, Ruxandra M Ionescu, Tim Schmeiser, Joerg H W Distler, Armando Gabrielli, Anna-Maria Hoffmann-Vold, Masataka Kuwana, Yannick Allanore, Oliver Distler, null null
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD open 8 (2) (2022)
Toby M Maher, Maureen D Mayes, Michael Kreuter, Elizabeth R Volkmann, Martin Aringer, Ivan Castellvi, Maurizio Cutolo, Christian Stock, Nils Schoof, Margarida Alves, Ganesh Raghu, null null
Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis & rheumatology (Hoboken, N.J.) 73 (4) (2021)
Berta Magallares, David Lobo-Prat, Ivan Castellvi, Patricia Moya, Ignasi Gich, Laura Martinez-Martinez, Hye Sang Park, Ana Milena Millán, Ana Laiz, Cesar Diaz-Torné, Susana Fernandez, Hèctor Corominas
Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 Classification Criteria in SLE with Longstanding Disease. Journal of clinical medicine 10 (11) (2021)
Patricia Moya, Alejandro Fernandez Leon, Maria Emilia Corica, Valle Camacho Marti, Diego Alfonso López-Mora, Ivan Castellvi, Hèctor Corominas
"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica". PloS one 16 (9) (2021)
Leticia Alserawan, Patricia Peñacoba, Sandra Elizabet Orozco Echevarría, Diego Castillo, Esther Ortiz, Laura Martinez-Martinez, Esther Moga Naranjo, Pere Domingo, Ivan Castellvi, Cándido Juárez, Anais Mariscal
Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19. Diagnostics (Basel, Switzerland) 11 (11) (2021)
Alejandro Robles-Perez, Jordi Dorca, Ivan Castellvi, Joan Miquel Nolla, Maria Molina-Molina, Francisco Javier Narváez
Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data. Rheumatology international 40 (5) (2020)
Hèctor Corominas, Ivan Castellvi, Pere Domingo, Jordi Casademont
Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists. European journal of rheumatology 7 (Suppl 2) (2020)
Ivan Castellvi, Carmen Pilar Simeón, Monica Sarmiento, Jordi Casademont, Hèctor Corominas, Vicenç Fonollosa
Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers. PloS one 15 (12) (2020)
Tarek Carlos Salman Monte, Carlos Sánchez-Piedra, Monica Fernandez Castro, Jose Luis Andreu, Víctor M Martínez-Taboada, Alejandro Olivé, José Rosas, Raúl Menor, Beatriz Rodríguez, Ángel García-Aparicio, Francisco Javier Lopez Longo, Sara Manrique Arija, Jesus Alberto Garcia Vadillo, Susana Gil Barato, Ruth López-González, Carlos Galisteo, Jorge Gonzalez Martin, Esther Ruiz Lucea, Celia Erausquin, Sheila Melchor, Begoña Moreira, Enrique Raya Álvarez, Jose María Pego-Reigosa, Natalia Cid, Enrique Júdez, Clara Moriano, Francisco Javier Narváez, Hèctor Corominas, Blanca Garcia Magallon, Carlos A Guillén-Astete, Ivan Castellvi, Cristina Bohórquez, Javier Loricera, Joaquín Belzunegui, Óscar Illera, Vicenç Torrente-Segarra
Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome. Rheumatology international 40 (8) (2020)
Ivan Castellvi, Saioa Eguiluz, Alejandro Escudero-Contreras, Juan José Ríos, Jaime Calvo-Alén, José Luis Callejas-Rubio, Carlos De la Puente, Carmen Pilar Simeón, Francisco Javier Narváez, Gerard Espinosa, Patricia E Carreira, Manuel Rubio-Rivas, Juan José Alegre, Alfredo Guillén-Del-Castillo, Jose Andrés Román-Ivorra, Vicent Fonollosa, null null
LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients. Rheumatology international 39 (11) (2019)
Muriel Elhai, Marouane Boubaya, Oliver Distler, Vanessa Smith, Marco Matucci-Cerinic, Juan José Alegre Sancho, Marie-Elise Truchetet, Yolanda Braun-Moscovici, Florenzo Iannone, Pavel I Novikov, Alain Lescoat, Elise Siegert, Ivan Castellvi, Paolo Airó, Serena Vettori, Ellen De Langhe, Eric Hachulla, Anne Erler, Lidia Ananieva, Martin Krusche, F J López-Longo, Jörg H W Distler, Nicolas Hunzelmann, Anna-Maria Hoffmann-Vold, Valeria Riccieri, Vivien M Hsu, Maria R Pozzi, Codrina Ancuta, Edoardo Rosato, Carina Mihai, Masataka Kuwana, Lesley Ann Saketkoo, Carlo Chizzolini, Roger Hesselstrand, Susanne Ullman, Sule Yavuz, Simona Rednic, Cristian Caimmi, Coralie Bloch-Queyrat, Yannick Allanore, null null
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Annals of the rheumatic diseases 78 (7) (2019)

Ivan Castellvi.css-eqlu8i{font-size:small;padding-left:4px;} (Ivan Castellví, Iván Castellví)

Publication Activity (10 Years)

Top Topics

Top Venues

Ivan Castellvi (Ivan Castellví, Iván Castellví)